Biological Specimen Banks

• 

  Subject Areas on Research

  • "That's a good question": university researchers' views on ownership and retention of human genetic specimens. 
  • A Guide for a Cardiovascular Genomics Biorepository: the CATHGEN Experience. 
  • A Plan for Academic Biobank Solvency-Leveraging Resources and Applying Business Processes to Improve Sustainability. 
  • A call to standardize preanalytic data elements for biospecimens. 
  • A polygenic score for body mass index is associated with depressive symptoms via early life stress: Evidence for gene-environment correlation. 
  • A taxonomic monograph of Ipomoea integrated across phylogenetic scales. 
  • A trade secret model for genomic biobanking. 
  • Adiposity in relation to age at menarche and other reproductive factors among 300 000 Chinese women: findings from China Kadoorie Biobank study. 
  • Advancing Diagnostics to Address Antibacterial Resistance: The Diagnostics and Devices Committee of the Antibacterial Resistance Leadership Group. 
  • Analysis of educational materials and destruction/opt-out initiatives for storage and use of residual newborn screening samples. 
  • Best Practices for Obtaining Genomic Consent in Pediatric Traumatic Brain Injury Research. 
  • Biobanking for Metabolomics and Lipidomics in Precision Medicine. 
  • Biobanking in the COVID-19 Era and Beyond: Part 1. How Early Experiences Can Translate into Actionable Wisdom. 
  • Biobanking in the COVID-19 Era and Beyond: Part 2. A Set of Tool Implementation Case Studies. 
  • Biomarker science: direction for the scientific community. 
  • COVID-19 tissue atlases reveal SARS-CoV-2 pathology and cellular targets. 
  • Cancer incidence in relation to body fatness among 0.5 million men and women: Findings from the China Kadoorie Biobank. 
  • Centralized biorepositories for genetic and genomic research. 
  • Challenges in creating an opt-in biobank with a registrar-based consent process and a commercial EHR. 
  • Change in the Rate of Biological Aging in Response to Caloric Restriction: CALERIE Biobank Analysis. 
  • Characteristics associated with participation in DNA banking: The National Registry of Veterans with ALS. 
  • Comprehensive genomic studies: emerging regulatory, strategic, and quality assurance challenges for biorepositories. 
  • Development of a contemporary globally diverse HIV viral panel by the EQAPOL program. 
  • Diabetic nephropathy: a national dialogue. 
  • Distinctive clinical and genetic features of lean vs overweight fatty liver disease using the UK Biobank. 
  • Each patient is a research biorepository: informatics-enabled research on surplus clinical specimens via the living BioBank. 
  • Establishment and maintenance of a PBMC repository for functional cellular studies in support of clinical vaccine trials. 
  • Establishment of patient-derived organoid models of lower-grade glioma. 
  • Ethical, legal, and social implications of biobanks for genetics research. 
  • Examination and prognostic implications of the unique microenvironment of breast cancer brain metastases. 
  • Exploring Understanding of "Understanding": The Paradigm Case of Biobank Consent Comprehension. 
  • Frequency, Penetrance, and Variable Expressivity of Dilated Cardiomyopathy-Associated Putative Pathogenic Gene Variants in UK Biobank Participants. 
  • Fresh fruit consumption and all-cause and cause-specific mortality: findings from the China Kadoorie Biobank. 
  • Genomics. Genomics, biobanks, and the trade-secret model. 
  • Germline HOXB13 G84E mutation carriers and risk to twenty common types of cancer: results from the UK Biobank. 
  • Human biospecimen research: experimental protocol and quality control tools. 
  • Impact of Specimen Heterogeneity on Biomarkers in Repository Samples from Patients with Acute Myeloid Leukemia: A SWOG Report. 
  • Implementation of Good Clinical Laboratory Practice (GCLP) guidelines within the External Quality Assurance Program Oversight Laboratory (EQAPOL). 
  • Improving biobank consent comprehension: a national randomized survey to assess the effect of a simplified form and review/retest intervention. 
  • Informed consent for biobanking: consensus-based guidelines for adequate comprehension. 
  • Informed consent for biorepositories: assessing prospective participants' understanding and opinions. 
  • Loss-of-function genomic variants highlight potential therapeutic targets for cardiovascular disease. 
  • Machine Learning Approach to Classify Cardiovascular Disease in Patients With Nonalcoholic Fatty Liver Disease in the UK Biobank Cohort. 
  • Modification effect of ideal cardiovascular health metrics on genetic association with incident heart failure in the China Kadoorie Biobank and the UK Biobank. 
  • Multilaboratory evaluation of screening methods for detection of high-level aminoglycoside resistance in enterococci. National Committee for Clinical Laboratory Standards Study Group on Enterococci. 
  • National Heart, Lung, And Blood Institute Clinical Proteomics Working Group report. 
  • National Lung Cancer Screening Trial American College of Radiology Imaging Network Specimen Biorepository originating from the Contemporary Screening for the Detection of Lung Cancer Trial (NLST, ACRIN 6654): design, intent, and availability of specimens for validation of lung cancer biomarkers. 
  • Organizational improvements to enhance modern clinical epidemiology. 
  • Pathologic Considerations and Standardization in Mesothelioma Clinical Trials. 
  • Pregnancy, pregnancy loss, and the risk of cardiovascular disease in Chinese women: findings from the China Kadoorie Biobank. 
  • Racial and ethnic disparities among donor oocyte banks in the United States. 
  • RePORT International: Advancing Tuberculosis Biomarker Research Through Global Collaboration. 
  • Simplifying informed consent for biorepositories: stakeholder perspectives. 
  • Stakeholder views on returning research results. 
  • The College of American Pathologists Biorepository Accreditation Program: Results from the First 5 Years. 
  • The Genomics Research and Innovation Network: creating an interoperable, federated, genomics learning system. 
  • The National MDS Natural History Study: design of an integrated data and sample biorepository to promote research studies in myelodysplastic syndromes. 
  • The U.S. Culture Collection Network Responding to the Requirements of the Nagoya Protocol on Access and Benefit Sharing 
  • The challenges faced by living stock collections in the USA. 
  • The top clinical trial opportunities in therapeutic apheresis and neurology. 
  • US and Scottish health professionals' attitudes toward DNA biobanking. 
  • What Is Adequate Understanding? 
  • dictyBase, the model organism database for Dictyostelium discoideum. 
• 

  Keywords of People

  • Ferrari, Guido, Professor in Surgery, Molecular Genetics and Microbiology
  • Patz Jr., Edward F., James and Alice Chen Distinguished Professor of Radiology, Pathology